EVI1-rearranged: GATA2, MECOM(EVI1) AML is characterized by the repositioning of a distal GATA2 enhancer that activates MECOM expression leading to GATA2 haploinsufficiency. This evidence concerns the gene RUNX1 and acute myeloid leukemia.